Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022

J Neuromuscul Dis. 2024;11(1):233-252. doi: 10.3233/JND-230176.
No abstract available

Keywords: Bisphosphonates; bone density; glucocorticoid; vertebral fracture.

MeSH terms

  • Bone and Bones
  • Humans
  • Muscles
  • Muscular Dystrophy, Duchenne* / complications
  • Muscular Dystrophy, Duchenne* / therapy
  • Osteoporosis* / etiology
  • Osteoporosis* / therapy